Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol

BACKGROUND: Lipid-lowering therapy is guided by Low-density-lipoprotein cholesterol (LDL-c) levels, although the cardiovascular disease (CVD) risk could be better reflected by other lipid parameters. This study aimed at comparing a comprehensive lipid profile between patients with type 2 diabetes me...

Descripción completa

Detalles Bibliográficos
Autores principales: Fonseca, Liliana, Paredes, Sílvia, Ramos, Helena, Oliveira, José Carlos, Palma, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275418/
https://www.ncbi.nlm.nih.gov/pubmed/32505210
http://dx.doi.org/10.1186/s12944-020-01292-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275418/
https://www.ncbi.nlm.nih.gov/pubmed/32505210
http://dx.doi.org/10.1186/s12944-020-01292-w

Ejemplares similares